Finance

Lists
OSUR:NASDAQ
OraSure Technologies Inc
3,62 US$
0,00%
(0,00) 1D
13 ნოე, 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OSUR...
Open
3,61 US$
High
3,68 US$
Low
3,54 US$
Mkt. cap
249,95 მლნ.
Avg. vol.
615,61 ათ.
Volume
409,01 ათ.
52-wk high
4,58 US$
52-wk low
2,08 US$
EPS
-0,69 US$
Beta
1,08
Shares outstanding
69,05 მლნ.
No. of employees
500
Open
3,61 US$
High
3,68 US$
Low
3,54 US$
Mkt. cap
249,95 მლნ.
Avg. vol.
615,61 ათ.
Volume
409,01 ათ.
52-wk high
4,58 US$
52-wk low
2,08 US$
EPS
-0,69 US$
Beta
1,08
Shares outstanding
69,05 მლნ.
No. of employees
500
News stories
From web sources and news partners
Profile
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test. Wikipedia
About OraSure Technologies Inc
CEOCarrie Eglinton Manner
Employees500
Founded11 დეკ. 1987
Headquartersბეთლეჰემი, პენსილვანია, ამერიკის შეერთებული შტატები
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 1 analyst giving stock ratings to OSUR in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for OSUR in the last 3 months
Highest
Current 3,62 US$
7,00 US$ (+93,37%)
Average
7,00 US$ (+93,37%)
Lowest
7,00 US$ (+93,37%)
Analyst
Recommendation
Action
Price target
Projected
Date
William Bonello
Craig-Hallum
Buy
Initiated
7,00 US$
+93,4%
10/23/2026
Last report
10 ნოე. 2026
Fiscal period
Q3 2026
-0,15 US$ / -0,18 US$
+16,67%beat
Revenue / Est. (USD)
30,91 მლნ. / 31,02 მლნ.
-0,37%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
26,76 მლნ.
27,92 მლნ.
30,64 მლნ.
30,91 მლნ.
Cost of goods sold
15,80 მლნ.
16,06 მლნ.
17,32 მლნ.
16,94 მლნ.
Cost of revenue
15,80 მლნ.
16,06 მლნ.
17,32 მლნ.
16,94 მლნ.
Research and development expenses
11,42 მლნ.
13,39 მლნ.
9,44 მლნ.
7,63 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,90 მლნ.
20,39 მლნ.
21,03 მლნ.
18,55 მლნ.
Operating expense
27,32 მლნ.
33,78 მლნ.
30,47 მლნ.
26,18 მლნ.
Total operating expenses
43,12 მლნ.
49,83 მლნ.
47,79 მლნ.
43,12 მლნ.
Operating income
-16,35 მლნ.
-21,91 მლნ.
-17,15 მლნ.
-12,21 მლნ.
Other non operating income
1,87 მლნ.
128,00 ათ.
272,00 ათ.
83,00 ათ.
EBT including unusual items
-19,08 მლნ.
-22,81 მლნ.
6,30 მლნ.
-12,39 მლნ.
EBT excluding unusual items
-15,32 მლნ.
-21,45 მლნ.
-16,29 მლნ.
-11,64 მლნ.
Income tax expense
210,00 ათ.
-432,00 ათ.
55,00 ათ.
708,00 ათ.
Effective tax rate
-1,10%
1,89%
0,87%
-5,72%
Other operating expenses
-
-
-
-
Net income
-19,29 მლნ.
-22,38 მლნ.
6,25 მლნ.
-13,09 მლნ.
Net profit margin
-72,06%
-80,13%
20,40%
-42,37%
Earnings per share
-0,19
-0,24
-0,20
-0,15
Interest and investment income
-
1,22 მლნ.
1,20 მლნ.
1,05 მლნ.
Interest expense
-
-
-
-
Net interest expenses
-
1,22 მლნ.
1,20 მლნ.
1,05 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,95 მლნ.
-19,57 მლნ.
-14,78 მლნ.
-10,01 მლნ.
Gain or loss from assets sale
268,00 ათ.
-
-20,00 ათ.
746,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები